End-Stage Renal Disease Perspective

• The Kidney and COVID-19: What We Know so Far   Nephrologists Matthew Sparks and Samira Farouk, of the Freely Filtered podcast, discuss the kidney effects of COVID-19 -- what is and isn't clear in patients with and without preexisting kidney disease.
  Medscape Nephrology, August 10, 2020
• Could a VA Directive Overhaul Kidney Care? Directive 1053 may have gotten lost in the pandemic news, but it could have widespread implications for the management of CKD by nephrologists and primary care. Tejas Desai, MD, takes a closer look.
  Medscape Nephrology, July 06, 2020
• ERA-EDTA 2020 Read clinically focused news coverage of key developments from ERA-EDTA 2020
  Medscape Nephrology, June 09, 2020
• NKF 2020 Read clinically focused news coverage of key developments from NKF 2020
  Medscape Nephrology, March 23, 2020
• ISN 2020 Read clinically focused news coverage of key developments from ISN 2020
  Medscape Nephrology, March 17, 2020
• Cardios, Nephros, PCPs -- We're All Diabetologists Now Newer diabetes medications are proving effective in reducing CV events, hospitalizations for heart failure, and progression to dialysis. So where do these drugs belong?
  Medscape Diabetes & Endocrinology, March 05, 2020
• ACIP 2020 Child/Teen Immunization Schedule: The Highlights A quick tour of key changes in the 2020 ACIP child/adolescent immunization schedule.
  Medscape Pediatrics, February 04, 2020
• Dialysis Industry Mergers: Profits Rise as Outcomes Worsen An economic analysis of the dialysis industry shows how the usual benefits of mergers are negated in the healthcare industry by imprudent financial incentives and lack of true competitive market forces.
  Medscape Nephrology, December 09, 2019
• Palliative Care in End-Stage Renal Disease In this case, a social worker must respond to a patient who expresses that she would like to discontinue dialysis and knows that doing so means she will die soon.
  Medscape Nurses, December 04, 2019
• Trump Should Get Kudos for Looking at Kidney Dialysis, Transplant   Dr Art Caplan discusses President Trump's ideas regarding re-examination of dialysis and kidney transplant in the US, and the need to improve access to immunosuppressive drugs post-transplant.
  Medscape Business of Medicine, August 30, 2019
• Study Underscores Need for Long-term Follow-up After AKI Focusing on eGFR alone may underestimate long-term kidney damage in some patients with AKI, concludes Dr Nisha Bansal in reviewing a new study.
  Medscape Nephrology, August 30, 2019
• Advancing American Kidney Health: The Ultimate RCT? President Trump's Executive Order puts nephrology center stage. Tejas Desai, MD, reviews what the initiative entails for kidney disease clinicians and what details are yet to come.
  Medscape Nephrology, July 19, 2019
• How Do the Renal Data From CREDENCE and CARMELINA Compare?   Meg Jardine and Christoph Wanner, investigators from the CREDENCE and CARMELINA trials, respectively, discuss the implications for SGLT2 inhibitor and DPP-4 inhibitor use in patients with kidney disease.
  Medscape Diabetes & Endocrinology, June 25, 2019
• Just Say No to the ICD in Patients With Kidney Disease Little evidence supports the use of ICDs in patients with kidney disease. A bold new study in patients on dialysis suggests that the devices should be avoided. John Mandrola, MD, weighs in.
  theheart.org on Medscape, June 17, 2019
• ERA-EDTA 2019 Read clinically focused news coverage of key developments from ERA-EDTA 2019
  Medscape Nephrology, May 20, 2019
• Discarded No More: HCV-Infected Organs Advance Transplantation Direct-acting antiviral therapy has made the use of HCV-infected organs a reality. Here is an inside look at one liver transplant program as they deliberate this option for their patients.
  Medscape Gastroenterology, May 03, 2019
• Urinary Oxalate and CKD Progression: Is There an Association? Dr Bansal reviews a study that examines whether higher urinary oxalate excretion predisposes patients to kidney disease progression.
  Medscape Nephrology, May 02, 2019
• No Firm Answers for Kidneys From LIRICO and VALID Studies Is dual RAS blockade in patients with diabetes with kidney disease beneficial? Dr Desai reviews two studies designed to answer that question.
  Medscape Nephrology, April 26, 2019
• CREDENCE Takes SGLT2 Inhibitors 'to the Next Level' What are the clinical implications of the CREDENCE trial? Dr Harpreet Bajaj shares his perspective on this landmark study.
  Medscape Diabetes & Endocrinology, April 25, 2019
• Is CREDENCE a Game Changer for Diabetic Nephropathy? The medical community is marveling at the results of the CREDENCE trial. But can one study really change clinical practice? Perry Wilson shares his thoughts.
  Medscape Nephrology, April 17, 2019